In:
Palliative Medicine, SAGE Publications, Vol. 6, No. 3 ( 1992-07), p. 217-226
Abstract:
Providing effective pain control without side effects is a major challenge in patients with advanced cancer. Oral analgesics may not be practical for a variety of reasons, and several alternatives for parenteral administration are available, including patient-controlled analgesia (PCA). This is a report of a pilot study of the effectiveness, dose requirements, side effects and practicality of continuous subcutaneous morphine infusion delivered by PCA in nine patients. A review of the literature of subcutaneous morphine infusions and guidelines for use are described. Continuous subcutaneous infusion of morphine via a PCA device appears to be a safe and effective method of pain control in patients with advanced cancer.
Type of Medium:
Online Resource
ISSN:
0269-2163
,
1477-030X
DOI:
10.1177/026921639200600306
Language:
English
Publisher:
SAGE Publications
Publication Date:
1992
detail.hit.zdb_id:
2027566-3
Bookmarklink
